Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 62
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Walsh, James K. and Roth, Thomas 2017. Principles and Practice of Sleep Medicine.

    Baandrup, Lone Glenthøj, Birte Yding and Jennum, Poul Jørgen 2016. Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use. Psychiatry Research, Vol. 240, p. 163.

    Holliday, Simon M. Morgan, Simon Tapley, Amanda Henderson, Kim M. Dunlop, Adrian J. van Driel, Mieke L. Spike, Neil A. McArthur, Lawrence A. Ball, Jean Oldmeadow, Christopher J. and Magin, Parker J. 2016. The pattern of anxiolytic and hypnotic management by Australian general practice trainees. Drug and Alcohol Review,

    Page, Amy Theresa Potter, Kathleen Clifford, Rhonda and Etherton-Beer, Christopher 2016. Deprescribing in older people. Maturitas, Vol. 91, p. 115.

    Page, Amy T. Clifford, Rhonda M. Potter, Kathleen Schwartz, Darren and Etherton-Beer, Christopher D. 2016. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. British Journal of Clinical Pharmacology,

    Bourgeois, Jolyce Elseviers, Monique M. Van Bortel, Luc Petrovic, Mirko and Vander Stichele, Robert H. 2015. The impact of chronic benzodiazepine use on cognitive evolution in nursing home residents. Human Psychopharmacology: Clinical and Experimental, Vol. 30, Issue. 2, p. 85.

    Pollmann, André S. Murphy, Andrea L. Bergman, Joel C. and Gardner, David M. 2015. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacology and Toxicology, Vol. 16, Issue. 1,

    Shih, Hsin-I Lin, Che-Chen Tu, Yi-Fang Chang, Chia-Ming Hsu, Hsiang-Chin Chi, Chih-Hsien and Kao, Chia-Hung 2015. An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population. Medicine, Vol. 94, Issue. 17, p. e809.

    Yang, Chien-Ming Tseng, Cheng-Hsiang Lai, Yin-Shi and Hsu, Shih-Chieh 2015. Self-efficacy enhancement can facilitate hypnotic tapering in patients with primary insomnia. Sleep and Biological Rhythms, Vol. 13, Issue. 3, p. 242.

    Arora, Amit O'Neill, Andrew Crome, Peter and Martin, Finbarr C. 2014. Substance Use and Older People.

    Bourgeois, Jolyce Elseviers, Monique M. Van Bortel, Luc Petrovic, Mirko and Vander Stichele, Robert H. 2014. One-Year Evolution of Sleep Quality in Older Users of Benzodiazepines: A Longitudinal Cohort Study in Belgian Nursing Home Residents. Drugs & Aging, Vol. 31, Issue. 9, p. 677.

    Ciraulo, Domenic A. and Oldham, Mark 2014. The Effects of Drug Abuse on the Human Nervous System.

    Iliffe, Steve Kendrick, Denise Morris, Richard Masud, Tahir Gage, Heather Skelton, Dawn Dinan, Susie Bowling, Ann Griffin, Mark Haworth, Deborah Swanwick, Glen Carpenter, Hannah Kumar, Arun Stevens, Zoe Gawler, Sheena Barlow, Cate Cook, Juliette and Belcher, Carolyn 2014. Multicentre cluster randomised trial comparing a community group exercise programme and home-based exercise with usual care for people aged 65 years and over in primary care. Health Technology Assessment, Vol. 18, Issue. 49, p. 1.

    Konopka, Lukasz M. and Zimmerman, Elizabeth M. 2014. Clinical Neurotherapy.

    Leufkens, T. R. M. Ramaekers, J. G. de Weerd, A. W. Riedel, W. J. and Vermeeren, A. 2014. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study. Psychopharmacology,

    Nurminen, Janne Puustinen, Juha Lähteenmäki, Ritva Vahlberg, Tero Lyles, Alan Partinen, Markku Räihä, Ismo Neuvonen, Pertti J and Kivelä, Sirkka-Liisa 2014. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics. BMC Geriatrics, Vol. 14, Issue. 1,

    Paquin, Allison M Zimmerman, Kristin and Rudolph, James L 2014. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opinion on Drug Safety, Vol. 13, Issue. 7, p. 919.

    Puustinen, Juha Lähteenmäki, Ritva Polo-Kantola, Päivi Salo, Paula Vahlberg, Tero Lyles, Alan Neuvonen, Pertti J. Partinen, Markku Räihä, Ismo and Kivelä, Sirkka-Liisa 2014. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. European Journal of Clinical Pharmacology, Vol. 70, Issue. 3, p. 319.

    Thorell, Kristine Ranstad, Karin Midlöv, Patrik Borgquist, Lars and Halling, Anders 2014. Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatrics, Vol. 14, Issue. 1,

    Verhoeven, Veronique Lopez Hartmann, Maja Wens, Johan Sabbe, Bernard Dieleman, Peter Tsakitzidis, Giannoula Van Royen, Paul and Remmen, Roy 2014. Happy pills in nursing homes in Belgium: A cohort study to determine prescribing patterns and relation to fall risk. Journal of Clinical Gerontology and Geriatrics, Vol. 5, Issue. 2, p. 53.


Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life

  • H. V. CURRAN (a1), R. COLLINS (a1), S. FLETCHER (a1), S. C. Y. KEE (a1), B. WOODS (a1) and S. ILIFFE (a1)
  • DOI:
  • Published online: 01 November 2003

Background. Older adults are the main recipients of repeat prescriptions for benzodiazepine (BZD) hypnotics. BZDs can impair cognitive function and may not aid sleep when taken continuously for years. This study therefore aimed to determine if withdrawing from BZDs leads to changes in patients' cognitive function, quality of life, mood and sleep.

Method. One hundred and ninety-two long-term users of BZD hypnotics, aged [ges ]65 years, were identified in 25 general practices. One hundred and four who wished to withdraw were randomly allocated to one of two groups under double-blind, placebo controlled conditions: group A's BZD dose was tapered from week 1 of the trial; group B were given their usual dose for 12 weeks and then it was tapered. An additional group (C) of 35 patients who did not wish to withdraw from BZDs participated as ‘continuers’. All patients were assessed at 0, 12 and 24 weeks and 50% were re-assessed at 52 weeks.

Results. Sixty per cent of patients had taken BZDs continuously for >10 years; 27% for >20 years. Of all patients beginning the trial, 80% had successfully withdrawn 6 months later. There was little difference between groups A and B, but these groups differed from continuers (C) in that the performance of the withdrawers on several cognitive/psychomotor tasks showed relative improvements at 24 or 52 weeks. Withdrawers and continuers did not differ in sleep or BZD withdrawal symptoms.

Conclusions. These results have clear implications for clinical practice. Withdrawal from BZDs produces some subtle cognitive advantages for older people, yet little in the way of withdrawal symptoms or emergent sleep difficulties. These findings also suggest that, taken long-term, BZDs do not aid sleep.

Corresponding author
Professor H. Valerie Curran, Psychopharmacology Research Unit, Clinical Health Psychology, University College London, Gower Street, London WC1 6BT.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *